Research output per year
Research output per year
Fingerprint
Dive into the research topics where Maida Zivalj is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Anti-MIF Nbs, a novel tool
Mora Barthelmess, R., Zivalj, M. (Contributor), Lage Marques, B. (Contributor), Van Craenenbroeck, J. (Contributor), Jumapili, A. N. (Contributor), Vincke, C. (Contributor), Arnouk, S. (Contributor), Hadadi, E. (Contributor), Stijlemans, B. & Van Ginderachter, J., 26 Apr 2025.Research output: Unpublished contribution to conference › Poster
-
Characterization and validation of Lipocalin-2-targeting Nanobodies with application potential across various disease models
Zivalj, M., Vincke, C. (Contributor), Sánchez-Bayuela, T. (Contributor), Romao, E. (Contributor), Destrijcker, R. (Contributor), Ahmed, D. T. A. A. (Contributor), Mehmeti, N. (Contributor), Gupta, M. S. (Contributor), Schoonooghe, S. (Contributor), Hassanzadeh Ghassabeh, G. (Contributor), Arnouk, S. (Contributor), Raes, G. (Contributor), Jaisser, F. (Contributor), Sterckx, Y.G.-J. (Contributor), Van Ginderachter, J. (Contributor) & Stijlemans, B., 2025.Research output: Unpublished contribution to conference › Poster
-
IL-10 Plays a Critical Role in Mitigating Acute Anaemia Development During African Trypanosome Infection
Živalj, M., St. Martin, A., De Baetselier, P., Maksymova, L., Berghmans, F., Boon, L., Van Ginderachter, J. A., Magez, S., De Trez, C. & Stijlemans, B., Dec 2025, In: Pathogens. 14, 12, 17 p., 1276.Research output: Contribution to journal › Article › peer-review
Open Access -
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal Cavity
Lebegge, E., Kancheva, D., Van Craenenbroeck, J., Ernst, S., Bardet, P. M. R., Caro, A. A., Kiss, M., Jumapili, N. A., Barthelmess, R. M., Zivalj, M., Assaf, N., Ali, L., Elkrim, Y., Demuytere, J., De Jonge, J., Raes, G., Hadadi, E., Devoogdt, N., Vincke, C. & Movahedi, K. & 6 others, , May 2025, In: European Journal of Immunology. 55, 5, p. 1-10 10 p., e202551804.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
VSIG4-EXPRESSING MACROPHAGES CONTRIBUTE TO ANTI-PARASITIC AND ANTI-METASTATIC RESPONSES IN THE PERITONEAL CAVITY
Lebegge, E., Kancheva, D., Van Craenenbroeck, J., Ernst, S., Bardet, P. M. R., Caro, A. A., Kiss, M., Jumapili, N. A., Barthelmess, R. M., Zivalj, M., Assaf, N., Elkrim, Y., Demuytere, J., De Jonge, J., Raes, G., Hadadi, E., Devoogdt, N., Vincke, C., Vereecke, L. & Ceelen, W. & 4 others, , 1 May 2025Research output: Other contribution
Datasets
-
Dataset "Infection history imprints prolonged changes to the Kupffer cell epigenome, transcriptome and function of Kupffer cells"
Van Ginderachter, J. (Creator), Musrati, M. (Creator), Kancheva, D. (Creator), Stijlemans, B. (Creator), Azouz , A. (Creator), Mesbahi, S. (Creator), Hadadi, E. (Creator), Lebegge, E. (Creator), Ali, L. (Creator), De Vlaminck, K. (Creator), Scheyltjens, I. (Creator), Vandamme, N. (Creator), Zivalj, M. (Creator), Assaf, N. (Creator), Elkrim, Y. (Creator), Ahmidi, I. (Creator), Huart, C. (Creator), Lamkanfi, M. (Creator), Guilliams, M. (Creator), De Baetselier, P. (Creator), Goriely, S. (Creator) & Movahedi, K. (Creator), NCBI Gene Expression Omnibus, 12 Aug 2024
Dataset
-
Flt3L therapy induces a Treg-promoting cDC1 state in triple-negative breast cancer
Clappaert, E. (Speaker), Kancheva, D. (Contributor), Brughmans, J. (Contributor), Debraekeleer, A. (Contributor), Bardet, P. (Contributor), Elkrim, Y. (Contributor), Lacroix, D. (Contributor), Zivalj, M. (Contributor), Hamouda, A. E. I. (Contributor), Van Ginderachter, J. (Contributor), Deschoemaeker, S. (Contributor) & Laoui, D. (Contributor)
8 Jun 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models
Clappaert, E. (Speaker), Kancheva, D. (Contributor), Brughmans, J. (Contributor), Debraekeleer, A. (Contributor), Bardet, P. (Contributor), Elkrim, Y. (Contributor), Lacroix, D. (Contributor), Zivalj, M. (Contributor), Hamouda, A. E. I. (Contributor), Van Ginderachter, J. (Contributor), Deschoemaeker, S. (Contributor) & Laoui, D. (Contributor)
16 Oct 2023Activity: Talk or presentation › Talk or presentation at a conference
Thesis
-
Validation of anti-Lipocalin-2 Nanobodies (anti-Lcn-2 Nbs) as anti-tumor treatment
Stijlemans, B. (Co-promotor), Van Ginderachter, J. (Promotor), Raes, G. (Promotor) & Zivalj, M. ((PhD) Student), 4 Sept 2020Student thesis: Master's Thesis
-
Validation of anti-Lipocalin-2 Nanobodies (anti-Lcn-2 Nbs) as anti-tumor treatment
Živalj, M. ((PhD) Student), Van Ginderachter, J. (Promotor), Raes, G. (Promotor) & Stijlemans, B. (Co-promotor), 4 Sept 2020Student thesis: Master's Thesis